Literature DB >> 7824157

ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.

S Sorbi1, B Nacmias, P Forleo, S Latorraca, I Gobbini, L Bracco, S Piacentini, L Amaducci.   

Abstract

Recent studies have provided evidence of association of apolipoprotein E (ApoE) epsilon 4 allele and late onset familial and sporadic Alzheimer's disease (AD). Epidemiological studies have established allelic variation at the ApoE locus. We have analyzed the ApoE gene polymorphism in a sample of 446 Italian subjects. Our data confirm a significant association between epsilon 4 allele and sporadic AD. The frequency of epsilon 4 allele in early onset familial AD patients was comparable to control values suggesting that epsilon 4 allele does not represent a risk factor for early onset familial AD (EOFAD). Moreover, we found a not previously reported association between ApoE epsilon 2 allele and sporadic AD and EOFAD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824157     DOI: 10.1016/0304-3940(94)90054-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

Review 3.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Authors:  H Bickeböller; D Campion; A Brice; P Amouyel; D Hannequin; O Didierjean; C Penet; C Martin; J Pérez-Tur; A Michon; B Dubois; F Ledoze; C Thomas-Anterion; F Pasquier; M Puel; J F Demonet; O Moreaud; M C Babron; D Meulien; D Guez; M C Chartier-Harlin; T Frebourg; Y Agid; M Martinez; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

5.  Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample.

Authors:  Kumar B Rajan; Lisa L Barnes; Robert S Wilson; Jennifer Weuve; Elizabeth A McAninch; Denis A Evans
Journal:  J Am Geriatr Soc       Date:  2018-12-24       Impact factor: 5.562

6.  Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

Authors:  V S Rao; A Cupples; C M van Duijn; A Kurz; R C Green; H Chui; R Duara; S A Auerbach; L Volicer; J Wells; C van Broeckhoven; J H Growdon; J L Haines; L A Farrer
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

Review 7.  Secretases-related miRNAs in Alzheimer's disease: new approach for biomarker discovery.

Authors:  Seyedeh Nazanin Hajjari; Mehdi Mehdizadeh; Saeed Sadigh-Eteghad; Dariush Shanehbandi; Shahram Teimourian; Behzad Baradaran
Journal:  Neurol Sci       Date:  2017-08-08       Impact factor: 3.307

8.  Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease.

Authors:  J Bronzova; C M van Duijn; L M Havekes; P de Knijff; C Van Broeckhoven; A Hofman
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

9.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

10.  Cognitive impairment and the associated risk factors among the elderly in the Shanghai urban area: a pilot study from China.

Authors:  Jun-Peng Zhuang; Gang Wang; Qi Cheng; Li-Ling Wang; Rong Fang; Li-Hua Liu; Ran Xiong; Yu Zhang; Ya-Xing Gui; Wen-Yan Kang; Hui-Dong Tang; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2012-11-26       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.